Rowland Elwell

Company: Calliditas Therapeutics

Job title: Head of US Field Medical Affairs

Seminars:

Panel Discussion: IgA Nephropathy: Current Achievements, Unmet Needs, & Research Priorities 8:30 am

Explore a comprehensive overview of breakthroughs in IgAN therapies that improve renal outcomes. How far have we come in slowing disease progression and reducing proteinuria? Despite advancements, where do gaps still persist? Distil the limitations of existing therapies, variability in patient responses, and the challenges of predicting long-term outcomes. What hurdles remain for patients and…Read more

day: Pre-Conference Focus Day